Pular para o conteúdo principal

Doença da válvula tricúspide

Profissionais de Saúde

Os artigos de Referência Profissional são projetados para uso por profissionais de saúde. Eles são escritos por médicos do Reino Unido e baseados em evidências de pesquisa, diretrizes do Reino Unido e da Europa. Você pode encontrar o Doença da válvula cardíaca artigo mais útil, ou um dos nossos outros artigos de saúde.

Doença da válvula tricúspide

Tricuspid valve disease is less common than aortic or mitral valve disease. Tricuspid regurgitation (TR) is more common than tricuspid stenosis.

Estenose tricúspide12

Tricuspid stenosis is rare, occurring in less than 1% of patients with valvular heart disease and only 2.4% of all patients with tricuspid valve disease. More than 90% of patients with tricuspid stenosis have rheumatic heart disease.

In tricuspid stenosis, the tricuspid orifice becomes narrowed and obstructs blood flow from the right atrium to the right ventricle. The right atrium becomes hypertrophied, and right heart disease-induced heart failure develops without right ventricular dysfunction. The right ventricle remains underfilled and small.

The cause of tricuspid stenosis can be broadly classified into 3 categories:

  • Adquirida:

    • Rheumatic heart disease. By far the most common underlying cause, this is almost always associated with concomitant mitral stenosis.

    • Large infected vegetations.

    • Síndrome carcinoide.

    • Systemic disease such as lúpus eritematoso sistêmico e antiphospholipid antibody syndrome, due to the associated risk of nonbacterial thrombotic endocarditis.

    • Síndrome hipereosinofílica.

    • Fibrose endomiocárdica.

    • Benign tumours, eg, atrial myxoma.

    • Metastatic disease, particularly of renal or ovarian origin.

  • Congenital. This is very rare and usually associated with other cardiac abnormalities but is seen in:

    • Ebstein anomaly.

    • Fabry or Whipple diseases.

  • Iatrogênico:

    • Permanent pacing or ICD leads can sometimes cause valvular stenosis, including tricuspid stenosis.

    • It is a rare complication of surgery for tricuspid regurgitation.

    • Appetite suppressant drugs (for example, fenfluramine, phentermine, and methysergide).

    • Microdosing of some psychedelic drugs, typically lysergic acid diethylamide (LSD), psilocybin and 3,4-Methylenedioxymethamphetamine (MDMA).3

Tricuspid stenosis symptoms and signs2

Veja também o separado Auscultação cardíaca e Sopros cardíacos em crianças artigos.

A detecção requer uma avaliação cuidadosa, pois quase sempre está associada a lesões valvulares do lado esquerdo que dominam a apresentação. Os sinais clínicos são frequentemente mascarados por lesões valvulares associadas, especialmente a estenose mitral.

  • Low output symptoms of fatigue and weakness.

  • Weight loss and reduced appetite.

  • A sensation of a rapid neck pulse.

  • Right hypochondrial discomfort from liver distension, hepatic pulsation, ascites, and peripheral oedema, which may be severe compared to the degree of dyspnoea.

  • The lungs are usually clear in isolated tricuspid stenosis but there may be pulmonary oedema associated with concomitant mitral stenosis.

  • There is often an opening "snap" followed by a middiastolic rumble. The murmur increases in intensity with inspiration or exercise.

  • Pressão venosa jugular elevada.

Investigações2

  • LFTs may be abnormal (mildly raised unconjugated bilirubin, alkaline phosphatase, or aminotransferases) due to hepatic congestion.

  • ECG may show evidence of right atrial hypertrophy with tall peaked P waves; tall peaked T waves may be seen in leads II, III and aVF. Atrial fibrillation is seen in 50% of people with tricuspid stenosis.

  • A radiografia de tórax pode mostrar um átrio direito dilatado sem um segmento de artéria pulmonar aumentado.

  • Ecocardiografia is the most useful test - to detect and quantify tricuspid stenosis and for assessment of the dimensions of cardiac chambers, determination of right ventricular and pulmonary pressures and detection of associated other heart valve abnormalities.

  • Cateterismo cardíaco: pode ser necessário antes da cirurgia para avaliar a possível doença arterial coronariana. A cateterização do coração direito pode ajudar a determinar a gravidade da estenose e defeitos congênitos associados. A avaliação das válvulas aórtica e mitral através da cateterização do coração esquerdo é útil em pacientes com doença reumática.

Tricuspid stenosis treatment and management2

Terapia médica

Diuretics may be useful in the presence of heart failure symptoms but are of limited long-term efficacy. They also risk reducing the preload too significantly.

Percutaneous valvotomy

This is offered to patients with unacceptable surgical risk and absence of tumour, thrombus, vegetation, and insignificant or mild tricuspid regurgitation.

Cirurgia
Surgery is offered to patients with low or moderate operative risk, and those with significant tricuspid regurgitation. Valvotomy is usually used in cases of isolated tricuspid stenosis but surgical repair or replacement is offered in cases of mitral valve involvement. Repair is recommended where possible but replacement may be performed if needed. No differences in long-term outcomes have been established between bioprosthetic and mechanical valve, although mechanical valves tend to be preferred in carcinoid syndrome.

The operative mortality for isolated tricuspid stenosis is significant and increases if performed with other valvular surgery (10% and 16%, respectively).

Prognóstico

  • O prognóstico é geralmente bom, mas depende do prognóstico da doença subjacente, de outras anomalias cardíacas associadas e de arritmias associadas.

Regurgitação tricúspide145

Tricuspid regurgitation increases in incidence with age. The prevalence in the general population reaches 1.5% in men and 5.6% in women. Its prevalence is significantly higher among patients with left-sided valve disorders, particularly those with heart failure (HF), where it affects up to 23% of patients. In heart failure, tricuspid regurgitation is associated with a higher risk of mortality.

Tricuspid regurgitation can be characterised as primary (where an abnormality of the tricuspid valve is the cause) and secondary (where right atrial or ventricular dilatation is the cause):6

Causes of tricuspid regurgitation5

Primary tricuspid regurgitation:

  • Congenital:

    • Ebstein's anomaly.

    • Connective tissue disorders, such as Marfan's or Ehlers-Danlos syndrome.

    • Giant right atrium.

    • Tricuspid valve malformations.

  • Adquirida:

    • Endocardite infecciosa.

    • Iatrogenic (caused by permanent pacemaker or implantable cardioverter-defibrillator lead placement or removal).

    • Traumático.

    • Rheumatic valve disease.

    • Síndrome carcinoide.

    • Myxomatous degeneration.7

    • Endocarditis due to lúpus eritematoso sistêmicoou artrite reumatoide.

    • Fibrose endomiocárdica.

    • Drug-induced disease (the same drugs that can cause tricuspid stenosis can cause tricuspid regurgitation.

Secondary tricuspid regurgitation:

This is more common and the tricuspid valve is usually normal but regurgitation is caused by right atrial or ventricular dilatation due to:

  • Left-sided heart disease: Left ventricular dysfunction or left-sided valvular heart disease resulting in pulmonary hypertension.

  • Pulmonary hypertension: Cor pulmonale, pulmonary embolism, pulmonary hypertension of any cause left to right shunt.

  • Right atrial abnormalities: Atrial fibrillation.

  • Stenosis of the pulmonic valve or pulmonary artery.

  • Hipertireoidismo.

Tricuspid regurgitation symptoms and signs5

Veja também o separado Auscultação cardíaca e Sopros cardíacos em crianças artigos.

  • Clinical features of right sided heart failure including dyspnoea, fatigue, cyanosis, cold skin, oedema, and discomfort in the right hypochondrium.

  • Exercise intolerance.

  • Distended and pulsatile jugular vein.

  • Pressão venosa jugular is elevated with a prominent systolic 'v' wave.

  • High-pitched pansystolic murmur, most prominent in the fourth intercostal space in the left parasternal region. The murmur is accentuated during inspiration, with exercise, with legs raised, and with direct liver compression.

Investigações58

  • Abnormal LFTs may be present.

  • ECG: findings are usually nonspecific; they may show right atrial hypertrophy (tall peaked 'p' waves), incomplete right bundle-branch block, Q waves in lead V1, and atrial fibrillation. Right axis deviation may be present.

  • RX de tórax: mostra cardiomegalia acentuada com aumento do coração direito e derrames pleurais. Ascite com elevação diafragmática pode estar presente. Hipertensão arterial e venosa pulmonar são comuns.

  • Echocardiography: to detect and quantify tricuspid regurgitation and for assessment of the dimensions of cardiac chambers, determination of right ventricular and pulmonary pressures and detection of other associated heart valve abnormalities.

  • Cateterismo cardíaco: pode ser necessário antes da cirurgia para avaliar a possível doença arterial coronariana e ajudar a determinar a gravidade da regurgitação e defeitos congênitos associados.

Tratamento e manejo da regurgitação tricúspide59

Terapia médica

  • Diuretics are useful in the presence of right heart failure. ACE inhibitors can also be helpful.

  • O tratamento da hipertensão pulmonar pode ser indicado.

  • O controle do ritmo pode ajudar a diminuir a regurgitação tricúspide e conter a dilatação anular em pacientes com fibrilação atrial crônica.

Cirurgia
Tricuspid valve repair should be performed during left-sided surgery in patients with severe tricuspid regurgitation and for patients with mild-moderate tricuspid regurgitation and either dilatation of the tricuspid annulus or a previous history of right-sided heart failure.10

In endocarditis, the tricuspid valve is recommended to be removed and not immediately replaced. In those with carcinoid, a mechanical valve is preferred over a bioprosthesis.

Prognóstico

  • Severe tricuspid regurgitation has a poor prognosis, even if it may be well tolerated functionally for years.

  • Severe tricuspid regurgitation has been found to be a strong predictor of prognosis in various disease states.4

  • Patients with moderate or severe tricuspid regurgitation have increased mortality, with an observed survival of 10.2% at 15 years, with the highest mortality in patients with tricuspid regurgitation associated with left-sided heart disease. However, even in patients with isolated tricuspid regurgitation, the yearly mortality rate is 12.1%.11

  • Isolated tricuspid valve repair has a mortality of 10% though this may be due to delays in treatment.4

Atresia tricúspide12

Tricuspid atresia is a rare congenital cyanotic heart disease caused by the complete agenesis of the tricuspid valve. Presentations vary due to differences in the extent of pulmonary blood flow. It is caused by abnormal heart development during embryogenesis without an underlying genetic predisposition.

Sintomas de atresia tricúspide12

  • Most cases are diagnosed prenatally in MEDCs.

  • Tricuspid atresia is usually detected in infancy with cianose, insuficiência cardíaca e restrição de crescimento.

  • Cardiac murmurs are often present:

    • Um sopro pansistólico, que pode significar fluxo sanguíneo através do defeito do septo ventricular.

    • Colaterais arteriais sistêmico-pulmonares ou anastomoses arteriais para arteriais pulmonares criadas cirurgicamente para melhorar o fluxo sanguíneo pulmonar, o que pode causar um sopro contínuo.

    • Um sopro indicando regurgitação mitral, que pode estar presente.

  • Older patients may have clubbing.

  • Babies with a VSD and without pulmonary stenosis do not present with cyanosis and therefore may initially go undiagnosed. They tend to present with signs and symptoms of heart failure, such as tachypnoea or respiratory distress, poor feeding, and impaired growth. Notable findings upon physical examination include tachypnoea, tachycardia, and hepatomegaly.

Investigações

  • RX de tórax: a cardiomegalia geralmente está presente, com uma borda direita do coração proeminente (aumento do átrio direito). As marcações vasculares pulmonares geralmente estão diminuídas (mas podem estar aumentadas quando o fluxo pulmonar não está obstruído).

  • Other investigations include ECG, echocardiography, and cardiac catheterisation.

Tratamento e manejo da atresia tricúspide121314

  • Lactentes com fluxo sanguíneo pulmonar obstruído e hipoxemia grave necessitam de infusões urgentes de prostaglandina E para manter a patência do ducto arterioso.

  • Other non-surgical management includes oxygen therapy, prevention of bacterial endocarditis, and management of heart failure.

  • Most patients with tricuspid atresia require some form of surgical treatment during the first year of life; there are normally 2-3 stages of surgical management, ending in the definitive Fontan procedure.

Complicações

  • Êmbolos paradoxais, derrame, abscesso cerebral.

  • Policitemia.

  • Dilatação cardíaca progressiva.

  • Disfunção ventricular.

  • Insuficiência da válvula mitral.

  • Arritmias.

Prognóstico

Patients who do not have surgery have a high mortality in the first year of life. With surgical interventions, the majority survive well into adulthood. The operative mortality is consistently less than 2%. Recent studies have shown a transplant-free survival rate of 92% at 15 years.15

Atualizações exclusivas para profissionais de saúde

Mantenha-se informado com as últimas atualizações clínicas, insights profissionais e orientações baseadas em evidências. O boletim informativo Patient Pro seleciona conteúdo essencial para profissionais de saúde—entregue diretamente na sua caixa de entrada.

Por favor, insira um endereço de e-mail válido

Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

Leitura adicional e referências

  • British Heart Foundation
  • Otto CM, Nishimura RA, Bonow RO, et al; Diretriz ACC/AHA 2020 para o Manejo de Pacientes com Doença Valvar Cardíaca: Um Relatório do Comitê Conjunto de Diretrizes de Prática Clínica do American College of Cardiology/American Heart Association. J Am Coll Cardiol. 2 de fevereiro de 2021;77(4):e25-e197. doi: 10.1016/j.jacc.2020.11.018. Publicado online em 17 de dezembro de 2020.
  1. Diretrizes para o manejo da doença valvular cardíaca; Sociedade Europeia de Cardiologia (2025)
  2. Golamari R, Shams P, Alahmadi MH, et al; Tricuspid Stenosis.
  3. Rouaud A, Calder AE, Hasler G; Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins. J Psychopharmacol. 2024 Mar;38(3):217-224. doi: 10.1177/02698811231225609. Epub 2024 Jan 12.
  4. Sala A, Hahn RT, Kodali SK, et al; Tricuspid Valve Regurgitation: Current Understanding and Novel Treatment Options. J Soc Cardiovasc Angiogr Interv. 2023 Jul 5;2(5):101041. doi: 10.1016/j.jscai.2023.101041. eCollection 2023 Sep-Oct.
  5. Mulla S, Asuka E, Bora V, et al; Tricuspid Regurgitation.
  6. Dahou A, Levin D, Reisman M, et al; Anatomia e Fisiologia da Válvula Tricúspide. JACC Cardiovasc Imaging. 2019 Mar;12(3):458-468. doi: 10.1016/j.jcmg.2018.07.032.
  7. Tricuspid Valve Prolapse Associated With Myxomatous Degeneration; J A M van Son et al; Annals of Thoracic Surgery
  8. Tricuspid valve regurgitation: no longer the “forgotten valve”; Sociedade Europeia de Cardiologia
  9. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints; R T Hahn et al; Journal of the American College of Cardiology
  10. 2025 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); F Praz et al; European Heart Journal
  11. The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association; L J Davidson et al; American Heart Association
  12. Minocha PK, Horenstein MS, Phoon C; Tricuspid Atresia.
  13. Tricuspid Atresia and Fontan Circulation: Anatomy, Physiology, and Perioperative Considerations; M Garritty et al; Hearts
  14. Tricuspid atresia presenting in infancy. Survival and suitability for the Fontan operation; R C Franklin et al; Circulation
  15. Mery CM, De Leon LE, Trujillo-Diaz D, et al; Contemporary Outcomes of the Fontan Operation: A Large Single-Institution Cohort. Ann Thorac Surg. 2019 Nov;108(5):1439-1446. doi: 10.1016/j.athoracsur.2019.05.039. Epub 2019 Jul 4.

Histórico do artigo

As informações nesta página são escritas e revisadas por clínicos qualificados.

Farmácia online, tratamentos e serviços de saúde

Acesso simples a tratamentos confiáveis e serviços de saúde online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment